NCT03484364Completed
Engaging Native Hawaiian/Pacific Islanders and Activating Communities to Take Steps (ENACTS)
Source: ClinicalTrials.gov · Last updated 20 Oct 2025
Brief summary (registry, in English)
Our Specific Aims are: 1. At the individual level, to compare within-person change in BP and secondary outcomes between the intervention and control groups. 2. At the family level, to evaluate ENACTS' effects on BP and secondary outcomes as within-person change in family members who provide primary support, and as mean change in other adult family members who are not directly engaged in the intervention. 3. At the policy level, to evaluate the intervention's ability to influence grocery store policy on clearly identifying foods that are low in sodium or high in potassium, some of which might not be easily identified with existing labels (e.g., fresh produce). ENACTS combines empirically supported elements of existing programs, thus increasing its probability of success. It aligns with the American Heart Association's call for multilevel prevention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 182 (actual)
- First submitted
- 15 Mar 2018
- Start date
- 15 Jun 2018
- Primary completion date
- 24 Jan 2025
- Lead sponsor
- Washington State University
- Diseases
- High blood pressure
- NCT number
- NCT03484364
What you commit to
- Study type: Interventional
- Participants enrolled: 182
- From 15 Jun 2018 to the primary completion date, 24 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Currently undergoing dialysis or treatment for a terminal illness;
Other
- Pregnant or planning on becoming pregnant throughout the course of the study;
Who the study is looking for
- Self-reported physician diagnosis of hypertension and/or type 2 diabetes confirmed by a prescription for an anti-hypertensive medication and/or type 2 diabetes medication;
- Self-reported NHPI race;
- \*Age 18 years and older at enrollment;
- Measured systolic BP ≥ 140 mmHg on enrollment; measured baseline fasting glucose \>125
- reliable internet access
- computer or Smartphone
- current email address
- \*Ability to understand written and spoken English; and
- \*Ability and willingness to follow all study protocols.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Recruitment via Facebook and Internet Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.